NCT06952504 2026-04-17
TroFuse-033
Merck Sharp & Dohme LLC
Phase 3 Recruiting
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
AstraZeneca
Eikon Therapeutics
Genmab
M.D. Anderson Cancer Center